| Date | Form | Description | Docs | XBRL | Pages |
| 06/09/05 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
22 | |
| 05/02/05 | UPLOAD | SEC-generated letter |
|
1 | |
| 04/22/05 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
13 | |
| 04/15/05 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 04/01/05 | UPLOAD | SEC-generated letter |
|
3 | |
| 03/11/05 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
3 | |
| 03/11/05 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
3 | |
| 03/10/05 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
24 | |
| 02/23/05 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 02/23/05 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
Latest News & Events
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Read More...Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Read More...Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Read More...